Table of Contents
1. Executive Summary
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Spatial Genomics & Transcriptomics Market Trends and Forecast
3.3: Global Spatial Genomics & Transcriptomics Market by Product
3.3.1: Instruments
3.3.1.1: By Mode
3.3.1.1.1: Automated
3.3.1.1.2: Semi-automated
3.3.1.1.3: Manual
3.3.1.2: By Type
3.3.1.2.1: Sequencing Platforms
3.3.1.2.2: IHC (Immunohistochemistry)
3.3.1.2.3: Microscopy
3.3.1.2.4: Flow Cytometry
3.3.1.2.5: Mass Spectrometry
3.3.1.2.6: Others
3.3.2: Consumables
3.3.3: Software
3.3.3.1: Bioinformatics Tools
3.3.3.2: Imaging Tools
3.3.3.3: Storage & Management Databases
3.4: Global Spatial Genomics & Transcriptomics Market by Technology
3.4.1: Spatial Transcriptomics
3.4.1.1: Sequencing-Based Methods
3.4.1.1.1: Laser Capture Microdissection (LCM)
3.4.1.1.2: Transcriptome In-Vivo Analysis (TIVA)
3.4.1.1.3: In Situ Sequencing
3.4.1.1.4: Microtomy Sequencing
3.4.1.2: IHC
3.4.1.3: Microscopy-Based RNA Imaging Techniques
3.4.1.3.1: Single Molecule RNA Fluorescence In-Situ Hybridization (smFISH)
3.4.1.3.2: Padlock Probes/ Rolling Circle Amplification
3.4.1.3.3: Branched DNA Probes
3.4.2: Spatial Genomics
3.4.2.1: FISH (Fluorescence In-Situ Hybridization)
3.4.2.2: Microscopy-Based Live DNA Imaging
3.4.2.3: Genome Perturbation Tools
3.4.2.4: Massively-Parallel Sequencing
3.4.2.5: Biochemical Techniques
3.4.2.6: Others
3.5: Global Spatial Genomics & Transcriptomics Market by Application
3.5.1: Diagnostics & Disease Profiling
3.5.2: Drug Discovery
3.5.3: Others
3.6: Global Spatial Genomics & Transcriptomics Market by End Use
3.6.1: Translational Research
3.6.2: Academic Customers
3.6.3: Diagnostic Customers
3.6.4: Pharmaceutical Manufacturer
4. Market Trends and Forecast Analysis by Region
4.1: Global Spatial Genomics & Transcriptomics Market by Region
4.2: North American Spatial Genomics & Transcriptomics Market
4.2.1: Market by Product: Instruments, Consumables, and Software
4.2.2: Market by Technology: Spatial Transcriptomics and Spatial Genomics
4.2.3: Market by Application: Diagnostics & Disease Profiling, Drug Discovery, and Others
4.2.4: Market by End Use: Translational Research, Academic Customers, Diagnostic Customers, and Pharmaceutical Manufacturer
4.2.5: The United States Spatial Genomics & Transcriptomics Market
4.2.6: The Canadian Spatial Genomics & Transcriptomics Market
4.2.7: The Mexican Spatial Genomics & Transcriptomics Market
4.3: European Spatial Genomics & Transcriptomics Market
4.3.1: Market by Product: Instruments, Consumables, and Software
4.3.2: Market by Technology: Spatial Transcriptomics and Spatial Genomics
4.3.3: Market by Application: Diagnostics & Disease Profiling, Drug Discovery, and Others
4.3.4: Market by End Use: Translational Research, Academic Customers, Diagnostic Customers, and Pharmaceutical Manufacturer
4.3.5: The Spatial Genomics & Transcriptomics Market of United Kingdom
4.3.6: The German Spatial Genomics & Transcriptomics Market
4.3.7: The French Spatial Genomics & Transcriptomics Market
4.4: APAC Spatial Genomics & Transcriptomics Market
4.4.1: Market by Product: Instruments, Consumables, and Software
4.4.2: Market by Technology: Spatial Transcriptomics and Spatial Genomics
4.4.3: Market by Application: Diagnostics & Disease Profiling, Drug Discovery, and Others
4.4.4: Market by End Use: Translational Research, Academic Customers, Diagnostic Customers, and Pharmaceutical Manufacturer
4.4.5: The Chinese Spatial Genomics & Transcriptomics Market
4.4.6: The Indian Spatial Genomics & Transcriptomics Market
4.4.7: The Japanese Spatial Genomics & Transcriptomics Market
4.5: ROW Spatial Genomics & Transcriptomics Market
4.5.1: Market by Product: Instruments, Consumables, and Software
4.5.2: Market by Technology: Spatial Transcriptomics and Spatial Genomics
4.5.3: Market by Application: Diagnostics & Disease Profiling, Drug Discovery, and Others
4.5.4: Market by End Use: Translational Research, Academic Customers, Diagnostic Customers, and Pharmaceutical Manufacturer
4.5.5: Brazilian Spatial Genomics & Transcriptomics Market
5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Spatial Genomics & Transcriptomics Market by Product
7.1.2: Growth Opportunities for the Global Spatial Genomics & Transcriptomics Market by Technology
7.1.3: Growth Opportunities for the Global Spatial Genomics & Transcriptomics Market by Application
7.1.4: Growth Opportunities for the Global Spatial Genomics & Transcriptomics Market by End User
7.1.5: Growth Opportunities for the Global Spatial Genomics & Transcriptomics Market by Region
7.2: Emerging Trends in the Global Spatial Genomics & Transcriptomics Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Spatial Genomics & Transcriptomics Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Spatial Genomics & Transcriptomics Market
7.3.4: Certification and Licensing
8. Company Profiles of Leading Players
8.1: 10x Genomics, Inc.
8.2: Dovetail Genomics, LLC
8.3: Illumina, Inc.
8.4: S2 Genomics, Inc.
8.5: NanoString Technologies, Inc.
8.6: Seven Bridges Genomics, Inc.
8.7: orizon Discovery Group Plc
8.8: CARTANA AB
8.9: Advanced Cell Diagnostics, Inc.
8.10: Spatial Transcriptomics AB